2026-08587NoticeWallet

ANI Pharma's Bid to Import Key Controlled Drugs

Published Date: 5/4/2026

Notice

Summary

ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!

Free Policy Watch

New rules are filed every week. Most people never see them.

Pick a topic. PRIA watches every federal rule and tells you when one hits your household.

Pick a topic to get started

Analyzed Economic Effects

4 provisions identified: 2 benefits, 2 costs, 0 mixed.

No Import of Finished Dosage Forms

The notice states that authorization for this import registration will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Permit approval will be limited to activities consistent with 21 U.S.C. 952(a)(2).

Comment and Hearing Deadline

Registered bulk manufacturers and applicants may submit electronic comments or objections, or file a written request for a hearing, on ANI Pharmaceuticals Inc.'s importer application by June 3, 2026. Comments must be submitted through Regulations.gov or hearing requests sent to the DEA addresses listed in the notice.

Levorphanol Import Authorization Sought

ANI Pharmaceuticals applied to be registered to import Levorphanol (controlled substance code 9220, Schedule II) for distribution to customers. If the registration is granted, this import authorization would cover Levorphanol distribution as described in the application.

Tapentadol Import Limited to Research

ANI applied to import Tapentadol (controlled substance code 9780, Schedule II) only in small quantities for internal research and reference standards purposes. The application states no other activities for this drug code are authorized for this registration.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
5/4/2026
6/3/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in